Beximco Pharma commences exports to Jordan
Monday, 1 October 2007
FE Report
Beximco Pharmaceuticals Ltd, the leading drug manufacturer and largest exporter of the country, has started supplying its medicine to Jordan as the first company of Bangladesh, a company statement said Sunday.
Beximco Pharma has received marketing authorization for four products in Jordan and a number of other products are in the registration process, company officials said.
Jordan, which has around US $315 million pharmaceutical market, is heavily dependent on imported drugs and more than 70 per cent medicines are imported from Europe.
Nazmul Hassan, CEO of Beximco Pharma, said "Having a market size of around US $8 billion and growth rate second only to Southeast Asia and China, the Middle East is strategically important in our global expansion plan. Being a member of GAFTA and with its well developed infrastructure and a high standard healthcare system, Jordan has already established itself as a regional hub for healthcare services and pharmaceutical trade."
Beximco Pharmaceuticals Ltd, the leading drug manufacturer and largest exporter of the country, has started supplying its medicine to Jordan as the first company of Bangladesh, a company statement said Sunday.
Beximco Pharma has received marketing authorization for four products in Jordan and a number of other products are in the registration process, company officials said.
Jordan, which has around US $315 million pharmaceutical market, is heavily dependent on imported drugs and more than 70 per cent medicines are imported from Europe.
Nazmul Hassan, CEO of Beximco Pharma, said "Having a market size of around US $8 billion and growth rate second only to Southeast Asia and China, the Middle East is strategically important in our global expansion plan. Being a member of GAFTA and with its well developed infrastructure and a high standard healthcare system, Jordan has already established itself as a regional hub for healthcare services and pharmaceutical trade."